| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 02/21/2001 | EP1077261A2 A process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding sod |
| 02/21/2001 | EP1077259A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 02/21/2001 | EP1077256A1 Novel glutaminase, gene thereof and process for producing the same |
| 02/21/2001 | EP1077255A1 Nicotianamine synthase and gene encoding the same |
| 02/21/2001 | EP1077063A2 Methods for treating skin pigmentation |
| 02/21/2001 | EP1076720A2 NUCLEOTIDE SEQUENCES FOR DETECTING ENTEROHEMORRHAGIC $i(ESCHERICHIA COLI) (EHEC) |
| 02/21/2001 | EP1076711A2 Human apoptosis associated proteins |
| 02/21/2001 | EP1076710A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 02/21/2001 | EP1076709A2 Sucrose phosphate synthase |
| 02/21/2001 | EP1076708A2 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b 12 transport |
| 02/21/2001 | EP1076702A1 Human protease associated proteins |
| 02/21/2001 | EP1076698A2 Transgenic plant-derived human blood coagulation factors |
| 02/21/2001 | EP1076694A1 Methods and substances for preventing and treating autoimmune disease |
| 02/21/2001 | EP1076692A2 Crystallizable jnk complexes |
| 02/21/2001 | EP1076690A2 Methods for modulating differentiation |
| 02/21/2001 | EP1076689A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
| 02/21/2001 | EP1076666A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
| 02/21/2001 | EP0975609A4 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
| 02/21/2001 | CN1285002A Analysis of predisposition based on buman airway tripsin protease gene polymorphism |
| 02/21/2001 | CN1284997A Modified deacetoxycephalosporin C synthase (DAOCS) and x-ray structure |
| 02/21/2001 | CN1284994A Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 02/21/2001 | CN1284562A Promotor for delta 1-pyrroline-5-carboxylic acid synthetase gene in arabidopsis thaliana |
| 02/21/2001 | CN1284561A Proline transport protein gene in rice |
| 02/21/2001 | CN1284560A Fermentation prep. of metabolic products and nucleotide sequence of code sod gene |
| 02/21/2001 | CN1062309C Phytase and clone and expression of its gene |
| 02/20/2001 | US6191343 Molecular methods of hybrid seed production |
| 02/20/2001 | US6191267 Cloning and producing the N.BstNBI nicking endonuclease |
| 02/20/2001 | US6191258 Polypeptide which associates with symetric nucleotide sequences; for the artificial regulation of gene expression in plants |
| 02/20/2001 | US6191255 Isolated matrix metalloproteinase of given amino acid sequence having the activation capability of pro-matrix metalloproteinase 2; vectors; transformed cells; use in diagnosis of cancer |
| 02/20/2001 | US6191169 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 02/20/2001 | US6191105 Insulin free compositions with insulin-methyl(ethylene glycol)-o-hexanoic acid conjugate and composition with water in oil microemulsion |
| 02/20/2001 | US6191092 Diols and stabilizers for enzymes |
| 02/20/2001 | US6190905 Cleaning contact lens; incubating contact lens with proteolytic enzyme, wash several times in buffer, store for utilization |
| 02/20/2001 | US6190904 High-alkaline protease and its use arginine-substituted subtilisin composition and use |
| 02/20/2001 | US6190902 Deformylation of f-met peptides in bacterial expression system |
| 02/20/2001 | US6190900 Adjusted protease; for amplified stability and wash performance in detergent |
| 02/20/2001 | US6190899 Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
| 02/20/2001 | US6190898 Using a specific group of salts to selectively purify through crystallization a cellulase enzyme which lacks a cellulose binding domain; use in preventing backstaining during stonewashing; detergents |
| 02/20/2001 | US6190897 Nucleotide sequence coding hydrolase; for use in digestion of animal feeds |
| 02/20/2001 | US6190896 Active human cellular transglutaminase |
| 02/20/2001 | US6190895 For transgenic plants with altered levels of terpenoids |
| 02/20/2001 | US6190892 Microbial production of indigo |
| 02/20/2001 | US6190890 Amino acid sequence of enzyme with carboxymethyl cellulase, endoglucanase, and beta-glucanase activity; from aspergillus; food processing like vegetable or fruit juice manufacture; antifouling agents for membranes |
| 02/20/2001 | US6190881 Polynucleotide; recombinant production; drug screening of bactericides and enzyme inhibitors |
| 02/20/2001 | US6190879 Culturing microorganism in liquid, measuring ability of broth to incorporate putrescine into casein, measuring ability to convert hydroxylamine to hydroxamic acid, and selecting microorganisms which only catalyze casein formation |
| 02/20/2001 | US6190876 KUZ, a novel family of metalloproteases |
| 02/20/2001 | US6190875 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 02/20/2001 | US6190874 Methods for identifying compounds that bind to CSAPK-1 |
| 02/20/2001 | US6190869 Antisense inhibition of protein kinase C-theta expression |
| 02/20/2001 | US6190723 Neutralization of food allergens by thioredoxin |
| 02/20/2001 | US6190667 Contacting parental helicobacter strain with molecule in biological sample and contacting helicobacter strain deficient in urei gene with molecule; comparing acidity sensitivity of both strains; selecting molecule that increases acidity |
| 02/20/2001 | US6190663 Human MAP kinase homolog |
| 02/20/2001 | US6190661 Methods and compositions for the use of apurinic/apyrimidinic endonucleases |
| 02/20/2001 | US6190658 Genetically modified manganese superoxide dismutase for treating oxidative damage |
| 02/20/2001 | US6190189 Cellulases and coding sequences |
| 02/20/2001 | CA2206399C Method for secreting thrombopoietin polypeptides |
| 02/20/2001 | CA2205413C Detergent compositions containing specific lipolytic enzymes |
| 02/20/2001 | CA2139661C Maize pollen-specific polygalacturonase gene |
| 02/20/2001 | CA2125037C Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality |
| 02/20/2001 | CA2001115C Biocatalysts |
| 02/15/2001 | WO2001011074A2 Nucleic acids encoding zinc metalloproteases |
| 02/15/2001 | WO2001011071A2 Bioproduction of para-hydroxycinnamic acid |
| 02/15/2001 | WO2001011070A2 1,3-propanediol and polymer derivatives from a fermentable carbon source |
| 02/15/2001 | WO2001011057A1 Production of proteins |
| 02/15/2001 | WO2001011056A1 Production of proteins by autoproteolytic cleavage |
| 02/15/2001 | WO2001011055A1 Isoprenoid biosynthesis |
| 02/15/2001 | WO2001011054A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
| 02/15/2001 | WO2001011053A2 Soluble, active recombinant human mao-b |
| 02/15/2001 | WO2001011052A2 Monocellular or multicellular organisms for the production of riboflavin |
| 02/15/2001 | WO2001011051A2 Chimeric proteins |
| 02/15/2001 | WO2001011044A1 Tumor antigen |
| 02/15/2001 | WO2001011036A1 Method of enhancing plant resistance to pathogens |
| 02/15/2001 | WO2001011028A1 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof |
| 02/15/2001 | WO2001011027A1 New protein |
| 02/15/2001 | WO2001011026A1 Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2) |
| 02/15/2001 | WO2001011025A2 Crystallization and structure determination of staphylococcus aureus thymidylate kinase |
| 02/15/2001 | WO2001011024A2 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 02/15/2001 | WO2001011023A1 Treatment of inflammatory or malignant disease using dnazymes |
| 02/15/2001 | WO2001011021A1 Recombinant stabile cell clone, its production and use thereof |
| 02/15/2001 | WO2001011014A1 Process for producing copolymerized polyester |
| 02/15/2001 | WO2001010905A1 Medicinal compositions for inhibiting abnormal proliferation of vascular smooth muscle cells |
| 02/15/2001 | WO2001010904A1 Map |
| 02/15/2001 | WO2001010903A2 Proteases and protease inhibitors |
| 02/15/2001 | WO2001010896A2 Factor x analog with an improved ability to be activated |
| 02/15/2001 | WO2001010894A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/15/2001 | WO2001010886A2 Automated protein purification in the multiwell format by vacuum filtration |
| 02/15/2001 | WO2001010454A2 Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection |
| 02/15/2001 | WO2001010444A2 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 02/15/2001 | WO2001010220A2 Insect control system |
| 02/15/2001 | WO2001010205A1 Methods and materials relating to cd39-like polypeptides |
| 02/15/2001 | WO2000079267A3 Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer |
| 02/15/2001 | WO2000070945A3 Fatty acid elongation genes and uses thereof |
| 02/15/2001 | WO2000070016A3 Genetically modified plants tolerant of stress conditions |
| 02/15/2001 | WO2000068370A3 ib00180US MAIS |
| 02/15/2001 | WO2000068363A3 Elastase variants and substrates |
| 02/15/2001 | WO2000066709A3 Zymogen activation system |
| 02/15/2001 | WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 02/15/2001 | WO2000055346A3 Methods and materials for the rapid and high volume production of a gene knock-out library in an organism |
| 02/15/2001 | WO2000053636A3 Dsp-1 dual-specificity map kinase phosphatase |
| 02/15/2001 | WO2000052173A3 Cloned human sphingosine kinase homologues |